Masimo ROE 2007-2018 | MASI

Current and historical return on equity (ROE) values for Masimo (MASI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Masimo ROE for the three months ending September 30, 2018 was 20.29%.
Masimo ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.15B $0.91B 18.09%
2018-06-30 $0.13B $0.83B 16.49%
2018-03-31 $0.13B $0.77B 17.28%
2017-12-31 $0.13B $0.72B 18.97%
2017-09-30 $0.35B $0.72B 53.13%
2017-06-30 $0.34B $0.71B 60.82%
2017-03-31 $0.33B $0.63B 71.35%
2016-12-31 $0.30B $0.56B 82.69%
2016-09-30 $0.11B $0.33B 37.54%
2016-06-30 $0.10B $0.30B 36.50%
2016-03-31 $0.09B $0.27B 32.85%
2015-12-31 $0.08B $0.28B 28.79%
2015-09-30 $0.08B $0.27B 27.00%
2015-06-30 $0.08B $0.28B 25.31%
2015-03-31 $0.07B $0.33B 22.98%
2014-12-31 $0.07B $0.31B 23.10%
2014-09-30 $0.06B $0.28B 19.03%
2014-06-30 $0.06B $0.32B 18.90%
2014-03-31 $0.07B $0.35B 20.22%
2013-12-31 $0.06B $0.33B 19.11%
2013-09-30 $0.06B $0.31B 21.99%
2013-06-30 $0.06B $0.29B 21.31%
2013-03-31 $0.06B $0.28B 21.61%
2012-12-31 $0.06B $0.28B 21.67%
2012-09-30 $0.06B $0.31B 21.25%
2012-06-30 $0.06B $0.30B 21.91%
2012-03-31 $0.06B $0.28B 21.87%
2011-12-31 $0.06B $0.28B 23.04%
2011-09-30 $0.07B $0.30B 24.88%
2011-06-30 $0.07B $0.28B 26.51%
2011-03-31 $0.06B $0.26B 26.69%
2010-12-31 $0.07B $0.23B 31.98%
2010-09-30 $0.07B $0.25B 29.19%
2010-06-30 $0.07B $0.23B 27.28%
2010-03-31 $0.07B $0.21B 26.17%
2009-12-31 $0.05B $0.29B 20.17%
2009-09-30 $0.04B $0.27B 15.51%
2009-06-30 $0.04B $0.25B 16.47%
2009-03-31 $0.04B $0.24B 16.78%
2008-12-31 $0.03B $0.22B 16.20%
2008-09-30 $0.04B $0.21B 24.41%
2008-06-30 $0.04B $0.19B 23.60%
2008-03-31 $0.03B $0.17B 22.56%
2007-12-31 $0.02B $0.15B 25.27%
2007-09-30 $0.02B $0.14B 28.04%
2007-06-30 $0.01B $0.08B 62.34%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $6.825B $0.798B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $101.538B 22.68
Intuitive Surgical (ISRG) United States $62.929B 59.23
Edwards Lifesciences (EW) United States $36.708B 37.59
Fresenius Medical Care AG KGaA (FMS) Germany $24.505B 16.57
IDEXX Laboratories (IDXX) United States $18.185B 49.52
ABIOMED (ABMD) United States $16.332B 107.81
Hologic (HOLX) United States $13.523B 20.45
Teleflex (TFX) United States $13.173B 29.90
DexCom (DXCM) United States $12.930B 0.00
Varian Medical Systems (VAR) United States $12.041B 30.08
STERIS (STE) United Kingdom $10.392B 26.71
Penumbra (PEN) United States $5.141B 310.42
LivaNova (LIVN) United Kingdom $4.861B 31.20
Globus Medical (GMED) United States $4.688B 29.38
Integra LifeSciences Holdings (IART) United States $4.423B 21.55
Wright Medical Group (WMGI) Netherlands $3.941B 0.00
Cantel Medical (CMD) United States $3.599B 35.50
Inogen (INGN) United States $3.000B 64.75
Tandem Diabetes Care (TNDM) United States $2.811B 0.00
Integer Holdings (ITGR) United States $2.761B 23.10
Glaukos (GKOS) United States $2.420B 0.00
AVANOS MEDICAL, INC (AVNS) United States $2.365B 21.31
OPKO Health (OPK) United States $1.612B 0.00
Nevro (NVRO) United States $1.461B 0.00
Tactile Systems Technology (TCMD) United States $1.358B 216.18
ORTHOFIX MEDICAL INC (OFIX) United States $1.244B 35.93
Accelerate Diagnostics (AXDX) United States $1.166B 0.00
Luminex (LMNX) United States $1.161B 53.14
CryoLife (CRY) United States $1.098B 118.84
Pacific Biosciences Of California (PACB) United States $1.088B 0.00
Intersect ENT (XENT) United States $1.039B 0.00
Natus Medical (BABY) United States $0.943B 19.67
Mesa Laboratories (MLAB) United States $0.900B 36.80
AngioDynamics (ANGO) United States $0.871B 28.24
ViewRay (VRAY) United States $0.791B 0.00
Veracyte (VCYT) United States $0.771B 0.00
AxoGen (AXGN) United States $0.677B 0.00
TransEnterix (TRXC) United States $0.653B 0.00
Quotient (QTNT) Switzerland $0.640B 0.00
OrthoPediatrics (KIDS) United States $0.488B 0.00
Si-Bone (SIBN) United States $0.466B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.457B 0.00
Accuray (ARAY) United States $0.454B 0.00
Fluidigm (FLDM) United States $0.424B 0.00
GenMark Diagnostics (GNMK) United States $0.377B 0.00
Pulse Biosciences (PLSE) United States $0.344B 0.00
SeaSpine Holdings (SPNE) United States $0.324B 0.00
Neuronetics (STIM) United States $0.310B 0.00
Sientra (SIEN) United States $0.304B 0.00
IRadimed (IRMD) United States $0.292B 62.14
RTI Surgical (RTIX) United States $0.291B 46.70
Corindus Vascular Robotics (CVRS) United States $0.251B 0.00
Nuvectra (NVTR) United States $0.250B 0.00
CRH Medical (CRHM) Canada $0.234B 40.63
Helius Medical Technologies (HSDT) United States $0.173B 0.00
T2 Biosystems (TTOO) United States $0.163B 0.00
Ekso Bionics Holdings (EKSO) United States $0.126B 0.00
Sensus Healthcare (SRTS) United States $0.120B 0.00
Ra Medical Systems (RMED) United States $0.093B 0.00
ConforMIS (CFMS) United States $0.089B 0.00
Biosig Technologies (BSGM) United States $0.087B 0.00
Titan Medical (TMDI) Canada $0.083B 0.00
EDAP TMS (EDAP) France $0.081B 0.00
Apollo Endosurgery (APEN) United States $0.081B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.068B 0.00
Alphatec Holdings (ATEC) United States $0.061B 0.00
Second Sight Medical Products (EYES) United States $0.057B 0.00
Vermillion (VRML) United States $0.054B 0.00
OBALON THERPTCS (OBLN) United States $0.050B 0.00
Electromed (ELMD) United States $0.047B 24.13
Xtant Medical Holdings (XTNT) United States $0.045B 0.00
Microbot Medical (MBOT) United States $0.039B 0.00
Restoration Robotics (HAIR) United States $0.034B 0.00
Viveve Medical (VIVE) United States $0.033B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.027B 0.00
PAVmed (PAVM) United States $0.026B 0.00
Lianluo Smart (LLIT) China $0.025B 0.00
DarioHealth (DRIO) Israel $0.023B 0.00
ReWalk Robotics (RWLK) Israel $0.022B 0.00
Neovasc (NVCN) Canada $0.019B 0.00
Dynatronics (DYNT) United States $0.018B 0.00
Bioanalytical Systems (BASI) United States $0.015B 47.67
American Shared Hospital Services (AMS) United States $0.015B 11.13
Nanovibronix (NAOV) United States $0.012B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Avinger (AVGR) United States $0.011B 0.00
Presbia (LENS) Ireland $0.009B 0.00
Atossa Genetics (ATOS) United States $0.009B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
InspireMD (NSPR) Israel $0.008B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00